Scopus
YÖKSİS DOI Eşleşti
SJR Q2
Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
Cancer Epidemiology · Aralık 2023
Özet
Background: Lung cancer is the leading cause of cancer-related deaths worldwide. Before beginning lung cancer treatment, it is necessary to complete procedures such as suspecting lung cancer, obtaining a pathologic diagnosis, and staging. This study aimed to investigate the processes from suspicion of lung cancer to diagnosis, staging, and treatment initiation. Methods: The study was designed as a multicenter and cross-sectional study. Patients with lung cancer from various health institutions located in all geographic regions of Turkey were included in the study. The sociodemographic and clinical characteristics of the patients, the characteristics of the health institutions and geographic regions, and other variables of the lung cancer process were recorded. The time from suspicion of lung cancer to pathologic diagnosis, radiologic staging, and treatment initiation, as well as influencing factors, were investigated. Results: The study included 1410 patients from 29 different medical centers. The mean time from the initial suspicion of lung cancer to the pathologic diagnosis was 48.0 ± 52.6 days, 39.0 ± 52.7 days for radiologic staging, and 74.9 ± 65.5 days for treatment initiation. The residential areas with the most suspected lung cancer cases were highly developed socioeconomic zones. Primary healthcare services accounted for only 0.4% of patients with suspected lung cancer. The time to pathologic diagnosis was longer in the Marmara region, and the wait time for staging and treatment initiation was longer in Eastern and Southeastern Anatolia. Patients who presented to chest disease referral hospitals with peripheral lesions, those with early-stage disease, and those who were diagnosed surgically had significantly longer wait times. Conclusion: The time between pathologic diagnosis, staging, and treatment initiation in lung cancer was longer than expected. Increasing the role of primary healthcare services and distributing socioeconomic resources more equally will contribute to shortening the time to diagnosis and improve treatment processes for lung cancer.
YÖKSİS Kayıtları
Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
Cancer Epidemiology · 2023 SCI-Expanded
Doç. Dr. DİLEK ERGÜN →
Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
Cancer Epidemiology · 2023 SCI-Expanded
Prof. Dr. RECAİ ERGÜN →
Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
Cancer Epidemiology · 2023 SCI-Expanded
Prof. Dr. RECAİ ERGÜN →
Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
Cancer Epidemiology · 2023 SCI-Expanded
Prof. Dr. RECAİ ERGÜN →
Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
Cancer Epidemiology · 2023 SCI-Expanded
Doç. Dr. DİLEK ERGÜN →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 4 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 4 kaydı bulundu.
Fibrous pseudotumors of tunica albuginea tunica vaginalis and epididymis Report of two cases
2009 ISSN: 18777821 SCI-Expanded
Prof. Dr. NEVZAT SERDAR UĞRAŞ →
Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
2023 ISSN: 1877-7821 SCI-Expanded Q2
Prof. Dr. RECAİ ERGÜN →
Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
2023 ISSN: 1877-7821 SCI-Expanded Q3
Doç. Dr. DİLEK ERGÜN →
Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
2023 ISSN: 1877-7821 SCI-Expanded Q3
Prof. Dr. RECAİ ERGÜN →
Makale Bilgileri
Dergi
Cancer Epidemiology
Toplam Atıf
1 atıf
· Scopus
ISSN18777821
Yayın TarihiAralık 2023
Cilt / Sayfa87
Scopus ID2-s2.0-85174899508
Kurumlar
Abant Izzet Baysal University, Faculty of Medicine
Bolu Turkey
Antalya Training and Research Hospital
Antalya Turkey
Ataturk University, Faculty of Medicine
Erzurum Turkey
Baskent Üniversitesi, Ankara Hastanesi
Ankara Turkey
Bursa Uludağ Üniversitesi
Bursa Turkey
Çukurova Üniversitesi Tip Fakültesi
Adana Turkey
Dokuz Eylül Üniversitesi
Izmir Turkey
Dr. Ersin Arslan Training and Research Hospital
Gaziantep Turkey
Erciyes University, Faculty of Medicine
Kayseri Turkey
Erzurum City Hospital
Erzurum Turkey
Hacettepe Üniversitesi
Ankara Turkey
Kocaeli City Hospital
Kocaeli Turkey
Kocaeli Üniversitesi
İzmit Turkey
Koru Hospital
Ankara Turkey
Kütahya Sağlık Bilimleri Üniversitesi
Kutahya Turkey
Manisa Celâl Bayar Üniversitesi
Manisa Turkey
Medicana International Atasehir Hospital
Istanbul Turkey
Mersin Üniversitesi
Mersin Turkey
Muğla Sıtkı Koçman Üniversitesi
Mugla Turkey
Muğla Training and Research Hospital
Mugla Turkey
Ondokuz Mayis University, Medical School
Samsun Turkey
Ordu Üniversitesi
Ordu Turkey
Pamukkale Üniversitesi Tip Fakültesi
Denizli Turkey
Recep Tayyip Erdogan University
Rize Turkey
Sakarya Üniversitesi
Serdivan Turkey
Selçuk Tip Fakültesi
Konya Turkey
Trakya University, Faculty of Medicine
Edirne Turkey
University of Health Sciences
Istanbul Turkey
Van Training and Research Hospital
Van Turkey
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 1.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Cancer Epidemiology
Q2
SJR Skoru1,036
H-Index94
YayıncıElsevier Ltd
ÜlkeUnited Kingdom
Cancer Research (Q2)
Epidemiology (Q2)
Oncology (Q2)
Metrikler
1
Atıf